Camden Capital, LLC Pfizer Inc Transaction History

Camden Capital, LLC

  • $1.14 Billion
  • Q1 2024

A detailed history of Camden Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Camden Capital, LLC holds 66,797 shares of PFE stock, worth $1.87 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
66,797
Previous 64,161 4.11%
Holding current value
$1.87 Million
Previous $1.85 Million 0.32%
% of portfolio
0.16%
Previous 0.19%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$25.89 - $29.73 $68,246 - $78,368
2,636 Added 4.11%
66,797 $1.85 Million
Q4 2023

Feb 05, 2024
BUY
$26.13 - $33.94 $751,289 - $975,842
28,752 Added 81.2%
64,161 $1.85 Million
Q3 2023

Nov 03, 2023
SELL
$32.09 - $37.51 $378,405 - $442,317
-11,792 Reduced 24.98%
35,409 $1.17 Million
Q2 2023

Aug 09, 2023
BUY
$36.12 - $41.79 $214,083 - $247,689
5,927 Added 14.36%
47,201 $1.73 Million
Q1 2023

May 11, 2023
BUY
$39.39 - $51.28 $24,224 - $31,537
615 Added 1.51%
41,274 $1.68 Million
Q4 2022

Feb 13, 2023
BUY
$41.75 - $54.5 $1.24 Million - $1.62 Million
29,753 Added 272.81%
40,659 $2.08 Million
Q3 2022

Nov 08, 2022
BUY
$43.76 - $53.42 $90,670 - $110,686
2,072 Added 23.45%
10,906 $477,000
Q2 2022

Aug 03, 2022
BUY
$46.53 - $55.17 $28,848 - $34,205
620 Added 7.55%
8,834 $463,000
Q1 2022

May 06, 2022
BUY
$45.75 - $56.69 $45,658 - $56,576
998 Added 13.83%
8,214 $425,000
Q4 2021

Feb 28, 2022
SELL
$41.32 - $61.25 $382,953 - $567,665
-9,268 Reduced 56.22%
7,216 $426,000
Q4 2021

Feb 14, 2022
SELL
$41.32 - $61.25 $60,988 - $90,405
-1,476 Reduced 8.22%
16,484 $973,000
Q3 2021

Nov 03, 2021
BUY
$39.25 - $50.42 $206,965 - $265,864
5,273 Added 41.56%
17,960 $772,000
Q2 2021

Aug 16, 2021
BUY
$35.91 - $40.68 $29,015 - $32,869
808 Added 6.8%
12,687 $497,000
Q1 2021

May 10, 2021
BUY
$33.49 - $37.77 $67,683 - $76,333
2,021 Added 20.5%
11,879 $430,000
Q4 2020

Feb 04, 2021
BUY
$33.47 - $42.56 $82,704 - $105,165
2,471 Added 33.45%
9,858 $363,000
Q3 2020

Oct 30, 2020
BUY
$31.75 - $37.25 $234,537 - $275,165
7,387 New
7,387 $271,000
Q2 2020

Aug 11, 2020
SELL
$30.12 - $36.54 $212,346 - $257,607
-7,050 Closed
0 $0
Q1 2020

Apr 13, 2020
SELL
$27.03 - $38.62 $66,304 - $94,734
-2,453 Reduced 25.81%
7,050 $230,000
Q4 2019

Feb 10, 2020
BUY
$32.92 - $37.36 $312,838 - $355,032
9,503 New
9,503 $372,000

Others Institutions Holding PFE

# of Institutions
3,159
Shares Held
3.68B
Call Options Held
67.4M
Put Options Held
113M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email